Stay updated with breaking news from Joan Mannick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
E-book contains edited transcript of a historic two hour moderated round table discussion held October 11, 2021 at the virtual Targeting Metabesity conference.
NEW YORK, Feb. 16, 2022 /PRNewswire/ -- Cambrian Biopharma, a multi-asset longevity biotech, today announced a licensing agreement with Novartis t...
Startups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain
In 2014 ResTORbio spun off out of Novartis and went public to try a longevity drug as a vaccine-potentiating agent in the elderly. The company was led by Dr. Joan Mannick, a physician with deep interest in aging. The trial failed in Phase III providing valuable experience, and her work continues.
Share this article Share this article BOSTON, April 22, 2021 /PRNewswire/ -- Life Biosciences, a pioneering life sciences company targeting the biology of aging, today announced the publication of preclinical research demonstrating clinical benefit of its chaperone-mediated autophagy activator platform in mice models of Alzheimer's disease. The article, titled Cell on April 22, 2021. Chaperone-mediated autophagy (CMA) controls the levels of soluble proteins in cells. It has been proposed that the age-related decline of CMA leads to an increased concentration of insoluble proteins that may p...